samedan logo
 
 
spacer
home > ebr > winter 2003 > will demand exceed supply for biopharmaceutical manufacturing?
PUBLICATIONS
European BioPharmaceutical Review

Will Demand Exceed Supply for Biopharmaceutical Manufacturing?

Manufacturing capacities have increasingly become cause for much speculation; many biopharmaceutical market participants consider this to be a crucial issue which will make or break the industry's progression. Once a new drug is discovered and clinical trials are conducted and approved by the drug approval authorities, the actual task of manufacture for commercial application begins. Construction of manufacturing facilities is not an easy task and requires anywhere between three to five years with a typical investment of around US$500 million. In the current economic situation, where raising capital is a difficult undertaking, building biopharmaceutical manufacturing reactors is not easy.

Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Raju Adhikari, Mbiochem, Dphil, Research Analyst at Frost and Sullivan, Europe

Raju Adhikari, Mbiochem, DPhil is a Research Analyst at Frost and Sullivan, Europe. Since joining Frost and Sullivan, Raju has been involved in the research, analysis and production of market studies in the biotechnology field. His experience in the biotechnology sector comes from three years spent working at Everest Biotechnology Ltd, an emerging antibody company. As Chief Scientific Officer, his role involved Product Management, Business Development, Quality Control and Marketing/PR. Raju graduated with a First Class Masters degree from the University of Oxford. He received his doctorate, also from the University of Oxford, in the field of Immunology and has published several papers in scientific journals.

spacer
Raju Adhikari
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

EuroBiopartnering 2008

7-9 October 2008, Paris, France

EuroBiOpartnering 2008 gives you the unique opportunity to meet the relevant decision makers and opinion leaders from the international biotech community and offers you 3 days of partnering opportunities including one-to-one meetings, company presentations and further networking activities…
More info >>

 
News and Press Releases

Ultra slim and ultra quick


More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement